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Introduction:

Systemic Amyloidosis is a rare disorder in which
misfolded proteins deposit in extracellular areas
throughout the body. It can involve multiple organs,
including endocrine glands. Due to the rare nature of
the disease, it can be difficult to diagnose. We
present a case of a 69-year-old male with severe
orthostatic hypotension and nontoxic multinodular
goiter who was ultimately diagnosed with systemic
light chain amyloidosis

Case Presentation:

Discussion:

The patient was treated with a bortezomib-based regimen
for systematic amyloidosis, glucocorticoids for adrenal
insufficiency, and levothyroxine for post-operative
hypothyroidism. He had an excellent response to the
chemotherapy and marked improvement in his symptoms

Conclusion:

Figure 1. Thyroid ultrasound image
with generalized thyromegaly and
enlarged isthmus

Figure 2. Superior right thyroid nodule

A 69-year-old male presented to the Endocrinology
clinic after multiple hospital admissions for severe
orthostatic hypotension, weight loss, edema and
generalized weakness. On physical exam, he was
found to have orthostatic hypotension and
large goiter
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Figure 3. Representative histopathology of amyloid deposition in
thyroid gland

Aﬁrma genomic sequence classiﬁer

"suspicious" for malignancy (risk
of malignancy ~50%)

Thyroidectomy and Pathology

Benign thyroid parenchyma with
dense light chain amyloid
deposition

Further workup revealed systemic lambda light chain amyloidosis with renal
involvement with nephrotic syndrome and cardiac involvement

There have been few reports of systemic amyloidosis
resulting in secondary adrenal insufficiency. A review by
Ozdemir found asymptomatic amyloid deposition in 30-80%
of patients with systemic amyloidosis. Symptoms of amyloid
endocrine involvement can include compressive symptoms
and hormone deficiency, although patients with amyloid
goiter are typically euthyroid. This case illustrates a rare
presentation of systemic light chain amyloidosis, illustrating
some of the ways that systemic amyloidosis can impact
endocrine organs.
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